Canna Law Blog
OCTOBER 12, 2022
Based upon it’s “scientific and medical evaluation”, the FDA found marijuana supremely dangerous and formally recommended that the plant remain in schedule I. For anyone also wondering what effect re-scheduling would have on state-level industry, check out this old chestnut from 2016. Conclusion.
FloridaMarijuana.net
JULY 16, 2018
Luckily, the trepidation of getting caught with medical marijuana has an easy solution nowadays. The initial payment will cover the medical evaluation, and three different recommendations for medical cannabis, which will last for seven months.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JANUARY 30, 2019
To expand the number of manufacturers, the Drug Enforcement Administration (DEA) submitted a notice in the Federal Register on August 11, 2016, soliciting applications for licenses to manufacture marijuana for research purposes. Both DOJ and HHS agreed to conduct a medical and scientific evaluation of CBD independent of marijuana in 2015.
Cannabis Law Report
MARCH 25, 2019
The Attorney General forwards the request to the Health and Human Services Secretary and requests a scientific and medical evaluation and recommendation, as specified by 23 USC 811(b-c). State-compliant cannabis activity would no longer violate federal criminal law. The Attorney General can also initiate the process.
Expert insights. Personalized for you.
84 
Let's personalize your content